4f2m - Revision history

OCA at 04:30, 7 October 2022

OCA — Fri, 07 Oct 2022 04:30:08 GMT

←Older revision		Revision as of 04:30, 7 October 2022
Line 1:		Line 1:

	==Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10==		==Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10==
-	<StructureSection load='4f2m' size='340' side='right' caption='[[4f2m]], [[Resolution\|resolution]] 3.00Å' scene=''>	+	<StructureSection load='4f2m' size='340' side='right'caption='[[4f2m]], [[Resolution\|resolution]] 3.00Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Lk3_transgenic_mice Lk3 transgenic mice~~] and [~~http~~://en.wikipedia.org/wiki/~~Tgev_virulent_purdue Tgev~~ virulent ~~purdue~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4F2M FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [https://en.wikipedia.org/wiki/TGEV_virulent_Purdue TGEV virulent Purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4F2M FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [https://pdbe.org/4f2m PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [https://www.ebi.ac.uk/pdbsum/4f2m PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4f2m ProSAT]</span></td></tr>
-	~~<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])~~</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [~~http~~://pdbe.org/4f2m PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4f2m PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4f2m ProSAT]</span></td></tr>	+
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/Q0PKZ5_CVPPU Q0PKZ5_CVPPU]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 20:		Line 20:

	==See Also==		==See Also==
-	*[[3D structures ~~of monoclonal antibody~~\|3D structures ~~of monoclonal antibody~~]]	+	*[[Monoclonal Antibodies 3D structures\|Monoclonal Antibodies 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Lk3 transgenic mice~~]]	+	[[Category: Large Structures]]
-	[[Category: ~~Tgev~~ virulent ~~purdue~~]]	+	[[Category: Mus musculus]]
-	[[Category: Casasnovas~~, J M~~]]	+	[[Category: TGEV virulent Purdue]]
-	[[Category: Enjuanes, L]]	+	[[Category: Casasnovas JM]]
-	[[Category: Mudgal, G]]	+	[[Category: Enjuanes L]]
-	[[Category: Ordono, D]]	+	[[Category: Mudgal G]]
-	[[Category: Reguera, J]]	+	[[Category: Ordono D]]
-	[[Category: Santiago, C]]	+	[[Category: Reguera J]]
-	~~[[Category: Aminopeptidase n]]~~	+	[[Category: Santiago C]]
-	~~[[Category: Beta-barrel]]~~	+
-	~~[[Category: Cellular receptor]]~~	+
-	~~[[Category: Glycosylation]]~~	+
-	~~[[Category: Immunoglobulin]]~~	+
-	~~[[Category: Viral protein-immune system complex]]~~	+
-	~~[[Category: Virus entry]]~~	+
-	~~[[Category: Virus membrane]]~~	+
-	~~[[Category: Virus neutralization~~]]	+

OCA at 09:13, 11 August 2016

OCA — Thu, 11 Aug 2016 09:13:04 GMT

←Older revision		Revision as of 09:13, 11 August 2016
Line 1:		Line 1:
		+
	==Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10==		==Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10==
	<StructureSection load='4f2m' size='340' side='right' caption='[[4f2m]], [[Resolution\|resolution]] 3.00Å' scene=''>		<StructureSection load='4f2m' size='340' side='right' caption='[[4f2m]], [[Resolution\|resolution]] 3.00Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Mus_musculus Mus musculus~~] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F2M FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F2M FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [http://www.ebi.ac.uk/pdbsum/4f2m PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [http://pdbe.org/4f2m PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [http://www.ebi.ac.uk/pdbsum/4f2m PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4f2m ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4f2m" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
-	*[[~~Monoclonal Antibody~~\|~~Monoclonal Antibody~~]]	+	*[[3D structures of monoclonal antibody\|3D structures of monoclonal antibody]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Mus musculus~~]]	+	[[Category: Lk3 transgenic mice]]
	[[Category: Tgev virulent purdue]]		[[Category: Tgev virulent purdue]]
	[[Category: Casasnovas, J M]]		[[Category: Casasnovas, J M]]

OCA at 12:38, 4 January 2015

OCA — Sun, 04 Jan 2015 12:38:45 GMT

←Older revision		Revision as of 12:38, 4 January 2015
Line 3:		Line 3:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F2M FirstGlance]. <br>		<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F2M FirstGlance]. <br>
-	</td></tr><tr><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene><br>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	<tr><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>
-	<tr><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])</td></tr>
-	<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [http://www.ebi.ac.uk/pdbsum/4f2m PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [http://www.ebi.ac.uk/pdbsum/4f2m PDBsum]</span></td></tr>
-	<table>	+	</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 25:
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
	[[Category: Tgev virulent purdue]]		[[Category: Tgev virulent purdue]]
-	[[Category: Casasnovas, J M.]]	+	[[Category: Casasnovas, J M]]
-	[[Category: Enjuanes, L.]]	+	[[Category: Enjuanes, L]]
-	[[Category: Mudgal, G.]]	+	[[Category: Mudgal, G]]
-	[[Category: Ordono, D.]]	+	[[Category: Ordono, D]]
-	[[Category: Reguera, J.]]	+	[[Category: Reguera, J]]
-	[[Category: Santiago, C.]]	+	[[Category: Santiago, C]]
	[[Category: Aminopeptidase n]]		[[Category: Aminopeptidase n]]
	[[Category: Beta-barrel]]		[[Category: Beta-barrel]]

OCA at 09:19, 11 June 2014

OCA — Wed, 11 Jun 2014 09:19:26 GMT

←Older revision		Revision as of 09:19, 11 June 2014
Line 1:		Line 1:
-	[[~~Image:~~4f2m.~~jpg~~\|~~left~~\|~~200px~~]]	+	==Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10==
		+	<StructureSection load='4f2m' size='340' side='right' caption='[[4f2m]], [[Resolution\|resolution]] 3.00Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F2M FirstGlance]. <br>
		+	</td></tr><tr><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene><br>
		+	<tr><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4f5c\|4f5c]]</td></tr>
		+	<tr><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=398812 TGEV virulent Purdue])</td></tr>
		+	<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f2m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f2m OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4f2m RCSB], [http://www.ebi.ac.uk/pdbsum/4f2m PDBsum]</span></td></tr>
		+	<table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The coronaviruses (CoVs) are enveloped viruses of animals and humans associated mostly with enteric and respiratory diseases, such as the severe acute respiratory syndrome and 10-20% of all common colds. A subset of CoVs uses the cell surface aminopeptidase N (APN), a membrane-bound metalloprotease, as a cell entry receptor. In these viruses, the envelope spike glycoprotein (S) mediates the attachment of the virus particles to APN and subsequent cell entry, which can be blocked by neutralizing antibodies. Here we describe the crystal structures of the receptor-binding domains (RBDs) of two closely related CoV strains, transmissible gastroenteritis virus (TGEV) and porcine respiratory CoV (PRCV), in complex with their receptor, porcine APN (pAPN), or with a neutralizing antibody. The data provide detailed information on the architecture of the dimeric pAPN ectodomain and its interaction with the CoV S. We show that a protruding receptor-binding edge in the S determines virus-binding specificity for recessed glycan-containing surfaces in the membrane-distal region of the pAPN ectodomain. Comparison of the RBDs of TGEV and PRCV to those of other related CoVs, suggests that the conformation of the S receptor-binding region determines cell entry receptor specificity. Moreover, the receptor-binding edge is a major antigenic determinant in the TGEV envelope S that is targeted by neutralizing antibodies. Our results provide a compelling view on CoV cell entry and immune neutralization, and may aid the design of antivirals or CoV vaccines. APN is also considered a target for cancer therapy and its structure, reported here, could facilitate the development of anti-cancer drugs.

-	~~{{STRUCTURE_4f2m\| PDB=4f2m \| SCENE= }}~~	+	Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies.,Reguera J, Santiago C, Mudgal G, Ordono D, Enjuanes L, Casasnovas JM PLoS Pathog. 2012 Aug;8(8):e1002859. Epub 2012 Aug 2. PMID:22876187<ref>PMID:22876187</ref>

-	~~===Crystal structure of~~ a ~~TGEV coronavirus Spike fragment in complex with~~ the ~~TGEV neutralizing monoclonal antibody 1AF10===~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>

-	~~{{ABSTRACT_PUBMED_22876187}}~~	+	==See Also==
-		+	*[[Monoclonal Antibody\|Monoclonal Antibody]]
-	==~~About this Structure~~==	+	== References ==
-	[[~~4f2m~~]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA].	+	<references/>
-		+	__TOC__
-	==~~Reference~~==	+	</StructureSection>
-	<~~ref group="xtra">PMID:022876187<~~/~~ref~~><~~references group="xtra"~~/>	+
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
	[[Category: Tgev virulent purdue]]		[[Category: Tgev virulent purdue]]

OCA at 05:54, 22 August 2012

OCA — Wed, 22 Aug 2012 05:54:04 GMT

←Older revision		Revision as of 05:54, 22 August 2012
Line 1:		Line 1:
-	~~'''Unreleased structure'''~~	+	[[Image:4f2m.jpg\|left\|200px]]

-	~~The entry~~ 4f2m ~~is ON HOLD~~	+	{{STRUCTURE_4f2m\| PDB=4f2m \| SCENE= }}

-	~~Authors: Reguera, J., Santiago, C., Mudgal, G., Ordono, D., Enjuanes, L., Casasnovas, J.M.~~	+	===Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10===

-	~~Description: Crystal structure of~~ a ~~TGEV coronavirus Spike fragment in complex~~ with ~~the TGEV neutralizing monoclonal antibody 1AF10~~	+	{{ABSTRACT_PUBMED_22876187}}
		+
		+	==About this Structure==
		+	[[4f2m]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Tgev_virulent_purdue Tgev virulent purdue]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F2M OCA].
		+
		+	==Reference==
		+	<ref group="xtra">PMID:022876187</ref><references group="xtra"/>
		+	[[Category: Mus musculus]]
		+	[[Category: Tgev virulent purdue]]
		+	[[Category: Casasnovas, J M.]]
		+	[[Category: Enjuanes, L.]]
		+	[[Category: Mudgal, G.]]
		+	[[Category: Ordono, D.]]
		+	[[Category: Reguera, J.]]
		+	[[Category: Santiago, C.]]
		+	[[Category: Aminopeptidase n]]
		+	[[Category: Beta-barrel]]
		+	[[Category: Cellular receptor]]
		+	[[Category: Glycosylation]]
		+	[[Category: Immunoglobulin]]
		+	[[Category: Viral protein-immune system complex]]
		+	[[Category: Virus entry]]
		+	[[Category: Virus membrane]]
		+	[[Category: Virus neutralization]]

OCA: Protected "4f2m" [edit=sysop:move=sysop]

OCA — Wed, 16 May 2012 08:54:32 GMT

Protected "4f2m" [edit=sysop:move=sysop]

←Older revision

Revision as of 08:54, 16 May 2012

OCA: New page: '''Unreleased structure''' The entry 4f2m is ON HOLD Authors: Reguera, J., Santiago, C., Mudgal, G., Ordono, D., Enjuanes, L., Casasnovas, J.M. Description: Crystal structure of a TGEV...

OCA — Wed, 16 May 2012 08:54:31 GMT

New page: '''Unreleased structure''' The entry 4f2m is ON HOLD Authors: Reguera, J., Santiago, C., Mudgal, G., Ordono, D., Enjuanes, L., Casasnovas, J.M. Description: Crystal structure of a TGEV...

New page

'''Unreleased structure'''

The entry 4f2m is ON HOLD

Authors: Reguera, J., Santiago, C., Mudgal, G., Ordono, D., Enjuanes, L., Casasnovas, J.M.

Description: Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10